Corrigendum to 'The Role of eIF4E in Response and Acquired Resistance to Vemurafenib in Melanoma': [Journal of Investigative Dermatology, Volume 135, Issue 5, May 2015, Pages 1368-1376]

J Invest Dermatol. 2026 May;146(5):1444-1445. doi: 10.1016/j.jid.2025.10.594. Epub 2026 Mar 13.

Affiliations

¹ Experimental Medicine, Faculty of Medicine, McGill University, Montréal, QC, Canada.
² Segal Cancer Centre, Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, QC, Canada.
³ Experimental Medicine, Faculty of Medicine, McGill University, Montréal, QC, Canada; Segal Cancer Centre, Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, QC, Canada.

PMID: 41823940
DOI: 10.1016/j.jid.2025.10.594

No abstract available

Publication types

Published Erratum